Inactive Instrument

Insiders Achieve Life Sciences Inc Nasdaq

Equities

Achieve Life Sciences, Inc. Announces Board Changes	23-03-30	CI
Achieve Life Sciences Says Its Smoking Addiction Treatment Candidate Showed Better Quit Rates Than Placebo in Phase 3 Trial	22-04-27	MT
Achieve Life Sciences, Inc. Announces Appointment of Dr. Vaughn Himes to Board of Directors	22-03-14	CI
Achieve Life Sciences Starts Screening in Late-Stage Trial of Cytisinicline to Quit Smoking	22-01-25	MT
Achieve Life Sciences, Inc. Announces Board Resignations	21-03-30	CI
Achieve Life Sciences, Inc. Announces Board Appointments	21-03-15	CI
Achieve Life Sciences Promotes John Bencich to Chief Executive Officer	20-09-30	CI
Achieve Life Sciences, Inc. Announces Management Changes	20-09-30	CI
Achieve Life Sciences : Announces Successful Results from the Investigator-Initiated RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix (varenicline) as a Treatment to Quit Smoking	20-06-29	PU
Achieve Life Sciences, Inc. Announces Successful Results from the Investigator-Initiated RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix® (varenicline) as a Treatment to Quit Smoking	20-06-29	CI
Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2B Orca-1 Dose-Selection Trial	19-06-11	CI
Oncogenex Pharmaceuticals Inc. will Change its Name to Achieve Life Sciences, Inc	18-01-26	CI

No results for this search